Aconitum tanguticum (Maxim.) Stapf.: a review of its traditional uses, chemical constituents, and pharmacological effects
Abstract
Aconitum tanguticum (Maxim.) Stapf., commonly known as "Bangga" when used in combination with Aconitum naviculare (Brühl.) Stapf., is a traditional Tibetan medicine widely used in medicinal preparations. It is documented in the Si-Bu-Yi-Dian and Jing-Zhu-Ben-Cao and is mainly used to treat infectious and inflammatory conditions such as fever, liver and biliary disorders, lung diseases, gastroenteritis, influenza, and food poisoning. The primary bioactive ingredients of Bangga include diterpenoids, flavonoids, and phenolic acids. Additionally, extracts of Bangga have numerous beneficial biological activities, including antibacterial, anti-inflammatory, antiviral, and antitumor properties. The integration of traditional Tibetan medicinal formulas with modern pharmacological research can reveal new directions for clinical applications. For example, other formulas such as Ba-Wei-Zhang-Ya-Wan, An-Er-Ning-Ke-Li, and Er-Shi-Wu-Wei-Gui-Jiu-Wan have shown efficacy in treating cholecystitis, pediatric hand-foot-mouth disease and asthma, and osteoporosis, respectively. Previous phytochemical research has mainly focused on its alkaloids, flavonoids, phenolic acids, and volatile oils. Accordingly, this review presents a comprehensive overview of studies on the traditional uses, chemical composition, and modern pharmacological effects of Aconitum tanguticum (Maxim.) Stapf. This review systematically summarizes the multi-target pharmacological mechanisms of its alkaloids, flavonoids, and…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.